Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9517276 Compositions and methods for conjugating activatable antibodies

Patent 9517276 was granted and assigned to CytomX Therapeutics on December, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128102 Constrained conditionally activated binding proteins
0
Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12109273 Process for preparing antibody-drug conjugates with improved homogeneity
0
Edits on 29 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11992528 Compositions and methods for conjugating activatable antibodies
0
Edits on 15 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11981716 Activatable interleukin-2 polypeptides and methods of use thereof
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+317 characters)
Article

Patent abstract

The invention relates generally to compositions and methods for conjugating antibodies and activatable antibodies, and methods of partially reducing antibodies and/or activatable antibodies prior to conjugation, e.g., thiol-based conjugation, with an agent, e.g., a therapeutic and/or diagnostic agent.

Edits on 7 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11744893 Constrained conditionally activated binding proteins
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11744892 Constrained conditionally activated binding proteins
Edits on 16 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 16 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09517276 Compositions and methods for conjugating activatable antibodies US Patent 9517276 Compositions and methods for conjugating activatable antibodies

Infobox
Patent Number
0951727600
Patent Number
951727600
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0951727600
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
CytomX Therapeutics
CytomX Therapeutics
0
Current Assignee
CytomX Therapeutics
CytomX Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
095172760
Date of Patent
December 13, 2016
0
Patent Application Number
142962070
Date Filed
June 4, 2014
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=095172760
Patent Primary Examiner
‌
Phuong Huynh
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
CytomX Therapeutics
CytomX Therapeutics
0
Current Assignee
CytomX Therapeutics
CytomX Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
095172760
Date of Patent
December 13, 2016
0
Patent Application Number
142962070
Date Filed
June 4, 2014
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=095172760
Patent Primary Examiner
‌
Phuong Huynh
0
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09517276
Edits on 9 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09517276 Compositions and methods for conjugating activatable antibodies

Infobox
Is a
Patent
Patent
Patent applicant
CytomX Therapeutics
CytomX Therapeutics
Current assignee
CytomX Therapeutics
CytomX Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09517276
Date of patent
December 13, 2016
Patent application number
14296207
Date Filed
June 4, 2014
Patent primary examiner
‌
Phuong Huynh

Find more entities like US Patent 9517276 Compositions and methods for conjugating activatable antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.